AzTrials
AzTrials

TraumaNCT05449353

Trauma-informed Cognitive Behavioural Therapy (TiCBT) to Aid Reintegration of Repentant Terrorists and Their Families in Nigeria: A Pilot Study

A study testing Trauma-informed Cognitive Behaviour Therapy (TiCBT) in people with Trauma and Psychological, run by Tarela Ike.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of the study is to describe the feasibility, cultural appropriateness, and acceptability of Trauma-informed Cognitive Behaviour Therapy (TiCBT) to promote community healing and encourage the reintegration of repentant terrorists and their families to avoid reoffending. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Trauma, Psychological
What is being tested?
Trauma-informed Cognitive Behaviour Therapy (TiCBT)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
24 participants
Where
No sites listed yet
Study dates
31 Jul 2022to 30 Jun 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • community members who are victims of Boko Haram terrorism and had previous experiences of trauma/depression,
  • score five and above for the culturally-adapted Trauma Screening Questionnaire (Brewinn et al., 2002)
  • aged 18+ years,
  • able to give informed consent,
  • speak English
  • are residents or from areas within Nigeria including Maiduguri, Adamawa, and Plateau environs.

Who cannot join

  • less than 18 or above 85 years
  • unable to give consent
  • clinically diagnosed with severe PTSD/suicidal ideations or undergoing treatment
  • temporary or non-residents who are unlikely to be available for follow up

Trial locations and contacts

No sites are listed yet.

About this study

The aim of the study is to describe the feasibility, cultural appropriateness, and acceptability of Trauma-informed Cognitive Behaviour Therapy (TiCBT) to promote community healing and encourage the reintegration of repentant terrorists and their families to avoid reoffending.

Read the detailed description

The study will adopt a mixed-method single-arm experimental design. Approximately 24 participants will be recruited for the intervention. The Trauma-informed Cognitive Behaviour Therapy (TiCBT) is an 8-session intervention lasting approximately 1 hour each and designed to address trauma, dispel negative attitudes and encourage positive behaviour towards repentant terrorists. Measurement will be collected at baseline pre-intervention, end of intervention and three months post-intervention to determine its feasibility and effectiveness. Interviews will also be conducted post-intervention. Repeated-measures univariate analyses of variance (ANOVA) will be performed to examine differences between the pre- and post-intervention stages. Interviews will be analysed using thematic analysis.

Being tested
Trauma-informed Cognitive Behaviour Therapy (TiCBT)
Medical subject headings
Wounds and Injuries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Trauma-informed Cognitive Behaviour Therapy (TiCBT)Behavioural

    Group: Experimental (n=24 participants) will receive the TiCBT which consists of a total of 8-group integrated sessions lasting approximately 60 minutes per session every 3 days interval with 24 persons in the single group.

Study groups in NCT05449353
Study groupRoleWhat they receive
Trauma-infomed Cognitive Behavioural TherapyExperimentalExperimental (n=24 participants) will receive the TiCBT which consists of a total of 8-group integrated sessions lasting approximately 60 minutes per session every 3 days interval with 24 persons in the single group.
Receives: Behavioral: Trauma-informed Cognitive Behaviour Therapy (TiCBT)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Trauma Screening Questionnaire

    Change in traumatic experience is being assessed

    Measured: Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months post-intervention

  2. Patient Health Questionnaire

    Change in depression is being assessed

    Measured: Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months post-intervention

  3. Attitude Towards Repentant Terrorists and their Reintegration Scale

    Change in of attitude towards repentant terrorists is being assessed

    Measured: Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months post-intervention

  4. brief Verona Service Satisfaction Scale

    Change in service satisfaction is being assessed

    Measured: Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months post-intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Jul 2022
  2. Study start31 Jul 2022 (estimated)
  3. Primary completion30 May 2023 (estimated)
  4. Study completion30 Jun 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
24 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05449353
Sponsor's protocol ID
0000-0003-0516-0313a
Status last verified
Jul 2022
First submitted
4 Jul 2022
Last updated
8 Jul 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Trauma-informed Cognitive Behaviour Therapy (TiCBT) in people with Trauma and Psychological, run by Tarela Ike.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 8 Jul 2022. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Tarela Ike, PhD (07831163474 ext. 44, t.ike@tees.ac.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Trauma Screening Questionnaire (time frame: Change is being assessed at baseline, at 12 weeks end of intervention, at 3-months post-intervention). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jul 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in